Functional IOL Implantation in Patients With Epiretinal Membrane
Clinical Outcomes in Cataract Patients With Macular Epiretinal Membrane After Implantation of Functional Intraocular Lenses
1 other identifier
interventional
90
1 country
2
Brief Summary
We have designed this prospective study to evaluate macular involvement and epiretinal membrane (ERM) grading by OCT in eyes with ERM and to compare clinical outcomes after implantation of Enhance IOL with standard monofocal IOL in eyes with ERM grading preoperatively, aiming to find out whether functional IOL is benefit for patients with ERM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 21, 2024
CompletedFirst Submitted
Initial submission to the registry
December 4, 2024
CompletedFirst Posted
Study publicly available on registry
December 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 21, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 21, 2026
April 8, 2026
December 1, 2025
2 years
December 4, 2024
April 2, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
UDVA
Uncorrected distance visual acuity
1-day/1-week/1-month/3-months/6-monhts/1-year/2-years
Study Arms (2)
Functional IOL
EXPERIMENTALExperimental group
Monofocal IOL
OTHERControl Group
Interventions
Cataract patients scheduled for surgery will be evaluated by OCT, and those diagnosed with macular epiretinal membrane will be implanted in different IOLs according to the patients' decision: monodical IOL or functional IOL.
Eligibility Criteria
You may qualify if:
- Requirement for cataract extraction
- Age \> 40 years
- Axial length in 21mm to 25mm
- ERM
You may not qualify if:
- Residual corneal astigmatism \> 1.0 D
- Amblyopia
- Previous ocular surgery
- Other ocular pathologies apart from mERM, such as diabetic retinopathy, macular degeneration, glaucoma with field defects
- Requirements for further ocular surgery (other than Nd:YAG capsulotomy) or retinal laser treatments during the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Eye and Ear, Nose, and Throat Hospital of Fudan University
Shanghai, Shanghai Municipality, 200031, China
Shanghai Heping Eye Hospital
Shanghai, Shanghai Municipality, 200081, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 4, 2024
First Posted
December 6, 2024
Study Start
September 21, 2024
Primary Completion (Estimated)
September 21, 2026
Study Completion (Estimated)
September 21, 2026
Last Updated
April 8, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share